Financials
Financial year 2025
STERIMED from Riemst, company number BE0862447784, closed financial year 2025 with a result of € 309,279 after tax. For that financial year STERIMED recorded a gross margin of € 734,071 and equity of € 759,376. Compared with financial year 2024, the result moved from € 3,336 to € 309,279. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 22, 2025.
€ 759,376
▲ 52% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 309,279
▲ € 305,943 vs 2024
Profit after tax over the fiscal year.
€ 887,083
▲ 107% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 50,000 paid out
16 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
4.4
▼ 0.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 240,743
▼ 11% vs 2024
€ 54,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 66,717
▼ 8% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 437,568
▼ 4% vs 2024
€ 83,982 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 157,750
Supplier invoices still open on the last day of the fiscal year.
€ 307,940
▲ 195% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 371,934 | € 502,916 | € 362,013 | € 734,071 | ▲ 103% |
| Profit after taxes | € 125,657 | € 182,331 | € 3,336 | € 309,279 | ▲ € 305,943 |
| Equity | € 329,430 | € 511,761 | € 500,097 | € 759,376 | ▲ 52% |
| Total debts | € 1,071,030 | € 923,289 | € 987,805 | € 1,172,898 | ▲ 19% |
| Cash | € 115,553 | € 392,944 | € 427,601 | € 887,083 | ▲ 107% |
| Land & buildings | € 496,810 | € 471,987 | € 447,165 | € 422,379 | ▼ 6% |
| Retained profit | € 310,830 | € 493,161 | € 481,497 | € 740,776 | ▲ 54% |
| Dividend | € 0 | € 0 | € 15,000 | € 50,000 | ▲ 233% |
| Bank debt | € 462,813 | € 463,808 | € 457,288 | € 437,568 | ▼ 4% |
| Balance sheet total | € 1,400,460 | € 1,435,050 | € 1,487,902 | € 1,932,274 | ▲ 30% |
| Employees (FTE) | 2.9 | 3.7 | 4.8 | 4.4 | ▼ 0.4 |
Key figures of STERIMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to STERIMED?
What happened at STERIMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 309,279 (▲ € 305,943 vs 2024). Source: NBB ↗
- New establishment in Riemst. KBO
- Start of the company according to the CBE. KBO
In short
From € 125,657 profit in 2022 to € 309,279 profit in 2025.
Paid € 230,147 in corporate taxes since 2022.
Best year ever: 2025, with € 309,279 profit.
On average € 166,800 of value added per employee in 2025.
A new publication or filing at STERIMED? We notify you, reason included.
Follow STERIMEDDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind STERIMED is Ludwig Stevens. The shares are held by Ludwig Stevens (55.4%) and Sandra Tits (44.6%).
Directors
According to the 2025 annual accounts
Ludwig Stevens
Manager
Shareholders
Ludwig Stevens
55.4%
Sandra Tits
44.6%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Biesenakkers 1
3770 Riemst
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Microsoft 365
Hosting
TRANSIP-AS Amsterdam, the Netherlands, NL
Website info
Features
Security
Details
- Company number
- 0862.447.784
- VAT number
- BE 0862.447.784
- Registered office
- Biesenakkers 1, 3770 Riemst
- Names & denominations
- STERIMED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 December 2003
- Peppol
- Active · Active since 22 Oct 2025
- Contact
- sterimed.be [email protected] 0473346455
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Verhuur en lease van medisch en paramedisch materieel
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels